Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
about
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD.Drug delivery to the lungs: challenges and opportunities.8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1.
P2860
Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-acting muscarinic antagon ...... obstructive pulmonary disease.
@en
type
label
Long-acting muscarinic antagon ...... obstructive pulmonary disease.
@en
prefLabel
Long-acting muscarinic antagon ...... obstructive pulmonary disease.
@en
P2860
P356
P1476
Long-acting muscarinic antagon ...... obstructive pulmonary disease.
@en
P2093
Paul W Jones
P2860
P356
10.1177/1753465815576471
P577
2015-03-22T00:00:00Z